Jefferies Reiterates Buy Rating on Humana (HUM)

Jefferies analyst David Windley reiterated a Buy rating and $419.00 price target on Humana (NYSE: HUM).

The analyst commented: "The recent 15% share decline since early Sept is due to fears HUM's ~2.8M PPO contract, H5216, falls from 4.5* to 3.5* and leaves a ~$9 EPS hole in 2026. Some of that negative outcome is priced in, but not all, which sets up a binary event that could see the stock move dramatically in either direction depending on the outcome. However, the math appears in HUM's favor and a 4* result should be the base case which skews risk/reward to the upside, in our view."

For an analyst ratings summary and ratings history on Humana click here. For more ratings news on Humana click here.

Shares of Humana closed at $313.04 yesterday.

You May Also Be Interested In

• 22nd Century Group files prospectus for warrant share resale
• MicroVision enters agreement to sell up to $42 million in common stock
• Nutrien warns shareholders about below-market mini-tender offer